The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression
Open accessAbstract
We investigated whether resveratrol (RV) affects azoxymethane (AOM)-induced colon carcinogenesis, by administering RV (200 microg/kg/day in drinking water) to male F344 rats for 100 days, beginning 10 days before carcinogen treatment (two weekly doses of 15 mg/kg AOM). Aberrant crypt foci (ACF) were isolated and proliferation, apoptosis and expression of the cell cycle genes bax and p21 were determined. RV significantly reduced the number of ACF/colon [25.7 +/- 3.6 (mean +/- SEM) versus 39.4 +/- 3.3 in controls; P < 0.01] and their multiplicity (2.7 +/- 0.3 versus 4.9 +/- 0.6 in controls; P < 0.01), and also abolished large ACF. In RV-treated rats, bax expression was enhanced in ACF but not in the surrounding mucosa. In both controls and RV-treated rats, proliferation was higher in ACF than in normal mucosa. p21 was expressed in ACF of controls and of RV-treated rats and in normal mucosa of controls, but was lost in normal mucosa of RV-treated animals. In conclusion, the results suggest a protective role of RV in colon carcinogenesis with a mechanism involving changes in bax and p21 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Inhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Colon Cancer: A Review of the Epidemiology
Potter, J. D., Slattery, M. L., Bostick, R. M., & Gapstur, S. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036132 · Cited by 765
Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H., & Talalay, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3147 · Cited by 745
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Clément, M.-V., Hirpara, J. L., Chawdhury, S.-H., & Pervaiz, S. (1998) · Blood · doi:10.1182/blood.v92.3.996 · Cited by 611
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535
Casper, R. F., Quesne, M., Rogers, I. M., Shirota, T., Jolivet, A., Milgrom, E., & Savouret, J.-F. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12541-2 · Cited by 416
Kawada, N., Seki, S., Inoue, M., & Kuroki, T. (1998) · Hepatology · doi:10.1002/hep.510270512 · Cited by 397
Cell-cycle arrest versus cell death in cancer therapy
Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., & Williams, J. (1997) · Nature Medicine · doi:10.1038/nm0997-1034 · Cited by 389
Resveratrol, a remarkable inhibitor of ribonucleotide reductase
Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., & Guittet, O. (1998) · FEBS Letters · doi:10.1016/s0014-5793(97)01572-x · Cited by 383
Hsieh, T.-C., & Wu, J. M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4471 · Cited by 361
Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
Huang, C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.237 · Cited by 338
Lu, R., & Serrero, G. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199906)179:3<297::aid-jcp7>3.0.co;2-p · Cited by 334
Aberrant crypts: potential preneoplastic lesions in the murine colon.
McLellan, E. A., & Bird, R. P. (1988) · PubMed · Cited by 304
Samaha, H. S., Kelloff, G. J., Steele, V. E., Rao, C. V., & Reddy, B. S. (1997) · PubMed · Cited by 292
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
Sharma, S., Stutzman, J. D., Kelloff, G. J., & Steele, V. E. (1994) · PubMed · Cited by 264
Resveratrol Arrests the Cell Division Cycle at S/G2 Phase Transition
Ragione, F. D., Cucciolla, V., Borriello, A., Pietra, V. D., Racioppi, L., Soldati, G., Manna, C., Galletti, P., & Zappia, V. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9263 · Cited by 262
DNA Polymerase and Topoisomerase II Inhibitors from Psoraleacorylifolia
Sun, N. J., Woo, S. H., Cassady, J. M., & Snapka, R. M. (1998) · Journal of Natural Products · doi:10.1021/np970488q · Cited by 262
Resveratrol, a Natural Product Present in Wine, Decreases Tumour Growth in a Rat Tumour Model
Carbó, N., Costelli, P., Baccino, F. M., López-Soriano, F. J., & Argilés, J. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9916 · Cited by 257
Hain, R., Bieseler, B., Kindl, H., Schr�der, G., & St�cker, R. (1990) · Plant Molecular Biology · doi:10.1007/bf00036918 · Cited by 248
McLellan, E. A., Medline, A., & Bird, R. P. (1991) · PubMed · Cited by 240
Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia.
Polyák, K., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1996) · Europe PMC (PubMed Central) · Cited by 118
Antioxidant activity of resveratrol in red wine
Miller, N. J., & Rice-Evans, C. A. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.12.1789 · Cited by 115
An Antiplatelet Principle ofVeratrum formosanum
Chung, M., Teng, C., Cheng, K.-L., Ko, F., & Lin, C. (1992) · Planta Medica · doi:10.1055/s-2006-961453 · Cited by 114
Polyethylene-glycol, a potent suppressor of azoxymethane-induced colonic aberrant crypt foci in rats
Corpet, D. E., & Parnaud, G. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.915 · Cited by 34
Premoselli, F., Sesca, E., Binasco, V., Caderni, G., & Tessitore, L. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980717)77:2<286::aid-ijc19>3.0.co;2-9 · Cited by 32
Self-citationLa, S., Chen, C., Rg, M., Steele, V., Rc, M., & Jm, P. (1994) · PubMed · Cited by 13
Cited by
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
I NHIBITION OF C ARCINOGENESIS BY D IETARY P OLYPHENOLIC C OMPOUNDS
Yang, C. S., Landau, J. M., Huang, M.-T., & Newmark, H. L. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.381 · Cited by 1,260
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051
Boocock, D. J., Faust, G. E. S., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0022 · Cited by 824
Metadata
- Authors
- Tessitore, L., Davit, A., Sarotto, I., & Caderni, G.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08-01
- Volume
- 21
- Issue
- 8
- Pages
- 1619-1622
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2146350175
- Cited by
- 282
- References
- 31
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.